[1] Liu L, Cao Y, Chen C, et al. Sorafenib blocks the RAF/MEK/ERK pathway, inhibits tumor angiogenesis, and induces tumor cell apoptosis in hepatocellular carcinoma model PLC/PRF/5[J]. Cancer Res, 2006, 66(24):11851-11858.
[2] Furuse J. Sorafenib for the treatment of unresectable hepatocellular carcinoma[J]. Biologics, 2008, 12(4):779-788.
[3] Wang XQ, Fan JM, Liu YO et al. Bioavailability and pharmacokinetics of sorafenib suspension, nanoparticles and nanomatrix for oral administration to rat[J]. Int J Pharm, 2011, 419(1-2):339-346.
[4] Kim MS. Soluplus-coated colloidal silica nanomatrix system for enhanced supersaturation and oral absorption of poorly water-soluble drugs[J]. Artif Cells Nanomed Biotechnol, 2013, 41(6):363-367.
[5] Wang L, Cui FD, Sunada H. Preparation and evaluation of solid dispersions of nitrendipine prepared with fine silica particles using the melt-mixing method[J]. Chem Pharm Bull, 2006, 54(1):37-43.
[6] Charnay C, Bégu S, Tourné-Péteilh C, et al. Inclusion of ibuprofen in mesoporous templated silica:drug loading and release property[J]. Eur J Pharm Biopharm. 2004, 57(3):533-540.
[7] Gupta P, Chawla G, Bansal AK. Physical stability and solubility advantage from amorphous celecoxib:the role of thermodynamic quantities and molecular mobility[J]. Mol Pharm, 2004, 1(6):406-413.
[8] Salonen J, Laitinen L, Kaukonen AM, et al. Mesoporous silicon microparticles for oral drug delivery:loading and release of five model drugs[J]. J Control Release, 2005, 108(2-3):362-374.
[9] Blanchet B, Billemont B, Cramard J, et al. Validation of an HPLC-UV method for sorafenib determination in human plasma and application to cancer patients in routine clinical practice[J]. J Pharm Biomed Anal, 2009, 49(4):1109-1114.
[10] Wang XQ, Dai JD, Zhang H, et al. Absorption mechanism of cyclosporine A loaded pH-sensitive nanoparticles in rats[J]. J Nanosci Nanotechnol, 2008, 8(5):2422-2431.
[11] Miller DA, Di Nunzio JC, Yang W, et al. Targeted intestinal delivery of supersaturated itraconazole for improved oral absorption[J]. Pharm Res, 2008, 25(6), 1450-1459.
[12] Janssens S, De Zeure A, Paudel A, et al. Influence of preparation methods on solid state supersaturation of amorphous solid dispersions:a case study with itraconazole and Eudragit E100[J]. Pharm Res, 2010, 27(5), 775-785.